Abstract
There is a growing need for efficient procedures for identification of emerging technologies by horizon scanning systems. We demonstrate the value of best-worst scaling (BWS) in exploring clinicians' views on emerging technologies that will impact outcomes in hepatocellular carcinoma (HCC) in the next 5 to 10 years.
Original language | English |
---|---|
Pages (from-to) | 339-46 |
Number of pages | 8 |
Journal | International Journal of Technology Assessment in Health Care |
Volume | 28 |
Issue number | 3 |
DOIs | |
Publication status | Published - Jul 2012 |
Keywords
- Asia
- Biomedical Technology
- Carcinoma, Hepatocellular
- Data Collection
- Europe
- Health Personnel
- Humans
- Liver Neoplasms
- Technology Assessment, Biomedical
- United States